"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 4 | 4 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 6 | 6 |
| 2000 | 0 | 9 | 9 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 18 | 18 |
| 2003 | 0 | 25 | 25 |
| 2004 | 0 | 21 | 21 |
| 2005 | 1 | 26 | 27 |
| 2006 | 0 | 16 | 16 |
| 2007 | 1 | 24 | 25 |
| 2008 | 0 | 20 | 20 |
| 2009 | 0 | 26 | 26 |
| 2010 | 1 | 26 | 27 |
| 2011 | 2 | 17 | 19 |
| 2012 | 2 | 21 | 23 |
| 2013 | 2 | 19 | 21 |
| 2014 | 3 | 23 | 26 |
| 2015 | 4 | 20 | 24 |
| 2016 | 5 | 16 | 21 |
| 2017 | 2 | 22 | 24 |
| 2018 | 2 | 15 | 17 |
| 2019 | 0 | 22 | 22 |
| 2020 | 3 | 24 | 27 |
| 2021 | 2 | 16 | 18 |
| 2022 | 1 | 12 | 13 |
| 2023 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 10 17; 330(15):1491-1492.
-
Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023 10 26; 186(22):4851-4867.e20.
-
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci. 2023 Nov 15; 454:120827.
-
Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023 Nov; 114:462-474.
-
Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions. J Neurol. 2023 Nov; 270(11):5162-5170.
-
T cell activation is insufficient to drive SIV disease progression. JCI Insight. 2023 07 24; 8(14).
-
Sex Differences in Alzheimer's Disease. Neurol Clin. 2023 05; 41(2):343-358.
-
Interstitial Lung Disease: A Focused Review for the Emergency Clinician. J Emerg Med. 2023 Feb; 64(2):156-166.
-
Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial. Inflamm Bowel Dis. 2022 12 01; 28(12):1872-1892.
-
Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness. JAMA Netw Open. 2022 12 01; 5(12):e2244486.